Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 05, 2016 6:35 PM ET

Capital Markets

Company Overview of CHL Healthcare Partners

Company Overview

CHL Healthcare Partners is a venture capital firm specializing in seed, start-up, and early stage investments. The firm typically invests in healthcare sector with a focus on biotechnology, molecular healthcare services, and life sciences tools and services. It targets companies focusing on consumer convenience including consumer healthcare and elder care, companies providing specialized service or a new care setting including general hospitals, companies addressing shortfall of access to care and providing efficient solutions to the administration of healthcare, service and product businesses specializing in new technology, drugs, and medical device. It primarily invests in companies based ...

1055 Washington Boulevard

6th Floor

Stamford, CT 06901

United States

Founded in 1997

Phone:

203-324-7700

Fax:

203-324-3636

Key Executives for CHL Healthcare Partners

Managing Partner and Partner
Age: 71
General Partner and Partner
Age: 57
Partner
Age: 47
Venture Partner
Age: 71
Compensation as of Fiscal Year 2015.

CHL Healthcare Partners Key Developments

Mevion Medical Systems, HOPU Investments, YuanMing Capital, Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners Forms Joint Venture to Produce, Sell and Service Proton Therapy Systems for the Chinese Market

Mevion Medical Systems announced that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion. The investment was led by HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and existing U.S. investors Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Concurrent with the investment, Mevion and the lead investors will form a joint venture in China to produce, sell and service proton therapy systems for the Chinese market. HOPU and YuanMing have extensive experience investing in successful healthcare companies and offer a significant network of healthcare experience in China.

Similar Private Companies By Industry

Company Name Region
Breckenridge Business Consultants United States
APS Investment Services, Inc. United States
Carnegie, Inc. United States
Albert Fried & Company, LLC, Research Division United States
IFG Network LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 24, 2015
Mevion Medical Systems, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHL Healthcare Partners, please visit www.chlhp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.